Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Cytoskeleton / ECM Cytoskeleton Intermediate Filaments Class II

FITC Anti-HLA-DR antibody [MEM-12] (ab28323)

Key features and details

  • FITC Mouse monoclonal [MEM-12] to HLA-DR
  • Reacts with: Human
  • Conjugation: FITC. Ex: 493nm, Em: 528nm
  • Isotype: IgG1

You may also be interested in

Product image
FITC Anti-HLA-DR antibody [LN3] (ab1182)
Product image
violetFluor™ 450 Anti-MHC Class II antibody [M5/114.15.2] (ab242262)
Anti-MHC Class II antibody [ER-TR3] (ab15630)
Product image
Anti-HLA-DR antibody [EPR3691(2)] - BSA and Azide free (ab248013)

Overview

  • Product name

    FITC Anti-HLA-DR antibody [MEM-12]
    See all HLA-DR primary antibodies
  • Description

    FITC Mouse monoclonal [MEM-12] to HLA-DR
  • Host species

    Mouse
  • Conjugation

    FITC. Ex: 493nm, Em: 528nm
  • Specificity

    ab28323 recognises HLA-DR.
  • Species reactivity

    Reacts with: Human
  • Immunogen

    Tissue, cells or virus corresponding to Human HLA-DR.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C.
  • Storage buffer

    pH: 7.4
    Preservative: 0.097% Sodium azide
    Constituents: PBS, 0.2% BSA
  • Concentration information loading...
  • Purity

    Protein A purified
  • Purification notes

    The purified antibody is conjugated with Fluorescein isothiocyanate (FITC). The reagent is free of unconjugated FITC and adjusted for direct use. No reconstitution is necessary.
  • Clonality

    Monoclonal
  • Clone number

    MEM-12
  • Isotype

    IgG1
  • Light chain type

    kappa
  • Research areas

    • Immunology
    • Adaptive Immunity
    • MHC
    • Class II

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to FITC Anti-HLA-DR antibody [MEM-12] (ab28323)

  •  
  • Product image

    Anti-HLA-DR antibody [EPR3692] - Low endotoxin, Azide free (ab215985)

    Applications: Flow Cyt, ICC/IF, IHC-P, Mass Cytometry, WB

  •  
  • Product image

    Anti-HLA-DR antibody [EPR21216] (ab226820)

    Applications: ICC/IF

  •  
  • Product image

    Anti-HLA-DR antibody [EPR3692] (ab92511)

    Applications: Flow Cyt, ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-HLA-DR antibody [EPR3691(2)] (ab124809)

    Applications: WB

  •  
  • Product image

    Anti-HLA-DR antibody [EPR21212] (ab227940)

    Applications: ICC/IF

  •  
  • Product image

    Anti-HLA-DR antibody [EPR21208] (ab213305)

    Applications: ICC/IF, IHC-P

  •  
  • Product image

    Alexa Fluor® 555 Anti-HLA-DR antibody [EPR3692] (ab215312)

    Applications: ICC/IF

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Stathmin 1 antibody [EP1573Y] - BSA and Azide free (ab221017)

  •  
  • Product image

    Anti-SEC22B antibody [EPR12335] - BSA and Azide free (ab250328)

  •  
  • Product image

    Anti-Caveolin-3 antibody [EPR11082] - BSA and Azide free (ab249773)

  •  
  • Product image

    Anti-IPPK/IPK1 antibody [EPR20893-54] - BSA and Azide free (ab269959)

  •  
  • Anti-Integrin alpha V antibody [RMV-7] (ab63490)

  •  
  • Product image

    Anti-heavy chain cardiac Myosin antibody [BA-G5] - BSA and Azide free (ab174640)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.